M.-P. Preziosi

535 total citations
9 papers, 410 citations indexed

About

M.-P. Preziosi is a scholar working on Microbiology, Epidemiology and Health. According to data from OpenAlex, M.-P. Preziosi has authored 9 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Microbiology, 8 papers in Epidemiology and 2 papers in Health. Recurrent topics in M.-P. Preziosi's work include Bacterial Infections and Vaccines (9 papers), Pneumonia and Respiratory Infections (7 papers) and Virology and Viral Diseases (3 papers). M.-P. Preziosi is often cited by papers focused on Bacterial Infections and Vaccines (9 papers), Pneumonia and Respiratory Infections (7 papers) and Virology and Viral Diseases (3 papers). M.-P. Preziosi collaborates with scholars based in France, Senegal and United States. M.-P. Preziosi's co-authors include Marie Paule Kiény, Jean‐Louis Preud'homme, Luc Hessel, Bernard Fritzell, François Simondon, S. Pinchinat, A Hoffenbach, J Taranger, Hubert J. Schmitt and Steven G.F. Wassilak and has published in prestigious journals such as Nature Reviews Microbiology, American Journal of Epidemiology and The Journal of Infectious Diseases.

In The Last Decade

M.-P. Preziosi

9 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.-P. Preziosi France 8 293 244 59 57 48 9 410
Lucy Roalfe United Kingdom 11 574 2.0× 200 0.8× 86 1.5× 50 0.9× 19 0.4× 19 668
James Wassil United States 9 306 1.0× 308 1.3× 33 0.6× 43 0.8× 15 0.3× 13 441
Frank Kowalzik Germany 9 237 0.8× 154 0.6× 61 1.0× 163 2.9× 65 1.4× 22 492
Arianna Neri Italy 16 414 1.4× 463 1.9× 27 0.5× 40 0.7× 28 0.6× 55 579
Leena Saarinen Finland 15 392 1.3× 350 1.4× 107 1.8× 51 0.9× 12 0.3× 19 533
Francesca Ceddia Italy 7 313 1.1× 308 1.3× 47 0.8× 37 0.6× 32 0.7× 12 405
Mary Matheson United Kingdom 12 401 1.4× 434 1.8× 49 0.8× 85 1.5× 67 1.4× 18 550
Tina M. Sterling United States 12 410 1.4× 82 0.3× 33 0.6× 46 0.8× 22 0.5× 24 454
Maja Jahnmatz Sweden 6 182 0.6× 163 0.7× 85 1.4× 66 1.2× 10 0.2× 6 296
Dorothee Kieninger Germany 11 680 2.3× 481 2.0× 86 1.5× 100 1.8× 73 1.5× 16 775

Countries citing papers authored by M.-P. Preziosi

Since Specialization
Citations

This map shows the geographic impact of M.-P. Preziosi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.-P. Preziosi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.-P. Preziosi more than expected).

Fields of papers citing papers by M.-P. Preziosi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.-P. Preziosi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.-P. Preziosi. The network helps show where M.-P. Preziosi may publish in the future.

Co-authorship network of co-authors of M.-P. Preziosi

This figure shows the co-authorship network connecting the top 25 collaborators of M.-P. Preziosi. A scholar is included among the top collaborators of M.-P. Preziosi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.-P. Preziosi. M.-P. Preziosi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Findlow, Helen, Brian D. Plikaytis, Audun Aase, et al.. (2009). Investigation of Different Group A Immunoassays following One Dose of Meningococcal Group A Conjugate Vaccine or A/C Polysaccharide Vaccine in Adults. Clinical and Vaccine Immunology. 16(7). 969–977. 22 indexed citations
2.
Preziosi, M.-P., et al.. (2006). A review of vaccine research and development: Meningococcal disease☆. Vaccine. 24(22). 4692–4700. 156 indexed citations
3.
Aguado, T., Eric Bertherat, Mamoudou Harouna Djingarey, et al.. (2004). Focus: Meningococcal meningitis. Nature Reviews Microbiology. 3(1). 10–10. 3 indexed citations
4.
Preziosi, M.-P.. (2003). Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. Vaccine. 21(17-18). 1853–1861. 51 indexed citations
5.
Preziosi, M.-P.. (2002). Epidemiology of Pertussis in a West African Community before and after Introduction of a Widespread Vaccination Program. American Journal of Epidemiology. 155(10). 891–896. 67 indexed citations
6.
Simondon, François, M.-P. Preziosi, S. Pinchinat, et al.. (1999). Randomised Study of the Possible Adjuvant Effect of BCG Vaccine on the Immunogenicity of Diphtheria-Tetanus-Acellular Pertussis Vaccine in Senegalese Infants. European Journal of Clinical Microbiology & Infectious Diseases. 18(1). 23–29. 19 indexed citations
7.
Preziosi, M.-P., et al.. (1997). The Senegal pertussis trial: safety and surveillance of adverse reactions.. PubMed. 89. 91–7. 9 indexed citations
8.
Heijbel, Harald, Marta Luisa Ciofi degli Atti, Johannes G. Liese, et al.. (1997). Hypotonic hyporesponsive episodes in eight pertussis vaccine studies.. PubMed. 89. 101–3. 22 indexed citations
9.
Preziosi, M.-P., et al.. (1992). Immunogenicity of Haemophilus influenzae Type b Conjugate Vaccine in Allogeneic Bone Marrow Recipients. The Journal of Infectious Diseases. 166(5). 1021–1028. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026